Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter Study Investigating Efficacy and Safety of Oral Rivaroxaban for the Prevention of Recurrent Venous Thromboembolism in Korean Patients With Cancers

NCT01989845 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01989845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01989845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter Study Investigating Efficacy and Safety of Oral Rivaroxaban for the Prevention of Recurrent Venous Thromboembolism in Korean Patients With Cancers
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2013
Completion date
December 31, 2016
Enrollment
127 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, cancer-associated thrombosis, recurrence, rivaroxaban